Arcadia Investment Management Corp MI Raises Stake in Medidata Solutions, Inc. (MDSO)
Arcadia Investment Management Corp MI boosted its position in Medidata Solutions, Inc. (NASDAQ:MDSO) by 2.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 47,040 shares of the company’s stock after buying an additional 1,145 shares during the period. Arcadia Investment Management Corp MI’s holdings in Medidata Solutions were worth $3,679,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently modified their holdings of MDSO. Clearbridge Investments LLC boosted its stake in shares of Medidata Solutions by 61.4% in the first quarter. Clearbridge Investments LLC now owns 2,449,038 shares of the company’s stock worth $141,285,000 after buying an additional 931,729 shares during the last quarter. Renaissance Technologies LLC boosted its stake in shares of Medidata Solutions by 562.8% in the first quarter. Renaissance Technologies LLC now owns 396,992 shares of the company’s stock worth $22,902,000 after buying an additional 337,098 shares during the last quarter. Teachers Advisors LLC boosted its stake in shares of Medidata Solutions by 254.0% in the first quarter. Teachers Advisors LLC now owns 371,554 shares of the company’s stock worth $21,435,000 after buying an additional 266,606 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Medidata Solutions by 5.1% in the first quarter. Vanguard Group Inc. now owns 4,874,974 shares of the company’s stock worth $281,237,000 after buying an additional 235,190 shares during the last quarter. Finally, Global Thematic Partners LLC boosted its stake in shares of Medidata Solutions by 36.5% in the first quarter. Global Thematic Partners LLC now owns 871,049 shares of the company’s stock worth $50,251,000 after buying an additional 232,810 shares during the last quarter.
Medidata Solutions, Inc. (NASDAQ:MDSO) opened at 74.70 on Tuesday. Medidata Solutions, Inc. has a 52-week low of $46.10 and a 52-week high of $85.92. The firm has a market capitalization of $4.23 billion, a price-to-earnings ratio of 120.68 and a beta of 1.79. The company’s 50-day moving average price is $77.77 and its 200 day moving average price is $66.69.
Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings data on Tuesday, July 18th. The company reported $0.31 EPS for the quarter, beating the Zacks’ consensus estimate of $0.28 by $0.03. The business had revenue of $137.41 million for the quarter, compared to analyst estimates of $134.28 million. Medidata Solutions had a return on equity of 11.14% and a net margin of 7.07%. The firm’s revenue for the quarter was up 19.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.24 EPS. Equities research analysts predict that Medidata Solutions, Inc. will post $1.28 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.watchlistnews.com/arcadia-investment-management-corp-mi-raises-stake-in-medidata-solutions-inc-mdso/1491443.html.
A number of analysts have recently issued reports on MDSO shares. Bank of America Corporation started coverage on Medidata Solutions in a report on Tuesday, June 6th. They set a “buy” rating and a $85.00 target price for the company. Zacks Investment Research cut Medidata Solutions from a “hold” rating to a “sell” rating in a report on Friday, July 21st. BidaskClub upgraded Medidata Solutions from a “hold” rating to a “buy” rating in a report on Wednesday, June 21st. Jefferies Group LLC upgraded Medidata Solutions from an “underperform” rating to a “hold” rating and decreased their target price for the stock from $47.00 to $46.00 in a report on Monday, May 1st. Finally, J P Morgan Chase & Co boosted their target price on Medidata Solutions to $87.00 and gave the stock an “overweight” rating in a report on Tuesday, July 18th. One analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $78.17.
In other news, Director Robert Taylor sold 5,639 shares of the stock in a transaction dated Monday, June 5th. The stock was sold at an average price of $73.46, for a total transaction of $414,240.94. Following the transaction, the director now owns 54,372 shares of the company’s stock, valued at approximately $3,994,167.12. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 5.80% of the company’s stock.
Medidata Solutions Company Profile
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions, Inc. (NASDAQ:MDSO).
Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.